CIMINO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.544
AS - Asia 6.920
EU - Europa 4.404
SA - Sud America 1.688
AF - Africa 208
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 7
Totale 23.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.225
SG - Singapore 2.038
CN - Cina 1.525
HK - Hong Kong 1.387
BR - Brasile 1.289
GB - Regno Unito 1.027
VN - Vietnam 863
IT - Italia 826
FI - Finlandia 601
SE - Svezia 490
RU - Federazione Russa 303
DE - Germania 293
KR - Corea 205
CA - Canada 200
FR - Francia 170
BG - Bulgaria 158
IN - India 158
AR - Argentina 135
NL - Olanda 127
UA - Ucraina 124
ID - Indonesia 115
TR - Turchia 113
BD - Bangladesh 90
JP - Giappone 82
EC - Ecuador 68
IQ - Iraq 68
EG - Egitto 61
MX - Messico 53
AT - Austria 49
ES - Italia 48
ZA - Sudafrica 46
CL - Cile 43
CO - Colombia 43
PL - Polonia 38
PE - Perù 37
AU - Australia 30
AE - Emirati Arabi Uniti 29
PK - Pakistan 28
IE - Irlanda 27
VE - Venezuela 26
MA - Marocco 25
MY - Malesia 25
PY - Paraguay 22
CZ - Repubblica Ceca 21
UZ - Uzbekistan 21
IL - Israele 18
SA - Arabia Saudita 18
UY - Uruguay 18
KW - Kuwait 17
BZ - Belize 16
DZ - Algeria 16
KE - Kenya 16
LT - Lituania 15
NP - Nepal 14
TN - Tunisia 14
TH - Thailandia 13
AL - Albania 12
BE - Belgio 10
PH - Filippine 10
TW - Taiwan 10
PT - Portogallo 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
IR - Iran 8
KZ - Kazakistan 8
RO - Romania 8
AZ - Azerbaigian 7
DK - Danimarca 7
JO - Giordania 7
SI - Slovenia 7
BO - Bolivia 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
PA - Panama 6
TT - Trinidad e Tobago 6
CY - Cipro 5
EU - Europa 5
JM - Giamaica 5
KG - Kirghizistan 5
OM - Oman 5
CR - Costa Rica 4
ET - Etiopia 4
MK - Macedonia 4
NO - Norvegia 4
PR - Porto Rico 4
AO - Angola 3
BH - Bahrain 3
GE - Georgia 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
LY - Libia 3
NG - Nigeria 3
RS - Serbia 3
SN - Senegal 3
CI - Costa d'Avorio 2
CV - Capo Verde 2
FJ - Figi 2
GA - Gabon 2
Totale 23.767
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.614
Hong Kong 1.370
Ashburn 1.278
Singapore 1.107
Fairfield 906
Helsinki 558
Chandler 459
London 453
Houston 449
Woodbridge 443
Nyköping 386
Southend 364
San Jose 353
Seattle 343
Beijing 327
Ho Chi Minh City 318
Cambridge 299
Wilmington 299
The Dalles 252
Ann Arbor 227
Hefei 213
Seoul 201
Hanoi 198
Los Angeles 188
Princeton 173
Jacksonville 166
New York 159
Sofia 153
Council Bluffs 151
Modena 148
San Diego 147
Toronto 143
Dearborn 139
Dallas 112
São Paulo 109
Moscow 101
Buffalo 91
Milan 87
Chicago 79
Lauterbourg 67
Shanghai 65
Capelle aan den IJssel 63
Jakarta 63
Nuremberg 52
Redondo Beach 50
Tokyo 50
Orem 48
Cairo 42
Frankfurt am Main 41
Rio de Janeiro 41
Columbus 39
Rome 39
Eugene 38
Guangzhou 35
Haiphong 34
Munich 34
Salt Lake City 34
Da Nang 30
Izmir 27
Warsaw 26
Bologna 25
Lima 25
Vienna 25
Brasília 24
Curitiba 24
Dublin 24
Santiago 24
Amsterdam 23
Baghdad 23
Biên Hòa 23
Quito 23
Belo Horizonte 22
Philadelphia 22
Porto Alegre 22
Montreal 21
Paris 21
Bengaluru 20
Denver 20
Melbourne 20
Reggio Emilia 20
Guayaquil 19
Johannesburg 18
Brooklyn 17
Kilburn 17
Kuwait City 17
Mexico City 17
Tashkent 17
Belize City 16
Elk Grove Village 16
Turin 16
Mumbai 15
Redwood City 15
Atlanta 14
Hyderabad 14
Kuala Lumpur 14
Manchester 14
Palermo 14
Phoenix 14
Thái Bình 14
Wuhan 14
Totale 16.244
Salva come PNG Salva come JPEG
Nome #
Visual loss and other cranial ischaemic complications in giant cell arteritis 325
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 311
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 310
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 304
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 286
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 277
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 274
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 259
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 253
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 252
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 252
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 251
Ophthalmic manifestations of cat scratch disease 250
Increased expression of interleukin-22 in patients with giant cell arteritis 249
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 249
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 246
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 242
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 239
Adalimumab in the treatment of immune-mediated diseases 236
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 236
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 235
The causes of uveitis in a referral centre of Northern Italy 233
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 232
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 229
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 220
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 216
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 215
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 213
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 213
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 209
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 208
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 207
Interleukin-10 promoter polymorphisms in giant cell arteritis 204
Tuberculous uveitis, a resurgent and underdiagnosed disease 203
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 203
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 200
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 198
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases (International Ophthalmology, (2017), 10.1007/s10792-016-0434-x) 196
Quasi cieco all'improvviso 192
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 191
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 190
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 188
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis 186
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 185
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 180
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 176
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 174
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review 174
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 174
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 172
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma 169
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 161
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 159
Surgical management of post-uveitic epiretinal membranes 157
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 156
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 156
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 153
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 151
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 151
Uveitis and other ocular complications following covid-19 vaccination 150
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 149
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 145
Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis 141
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 140
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 138
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 137
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 136
Eosinophilic giant cell arteritis: A different subset of disease? 136
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 134
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 134
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 133
Role of miR-146a and miR-146b in Giant Cell Arteritis. 132
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 132
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 132
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 130
Insight into giant cell arteritis pathogenesis by NanoString nCounter gene expression profiling in temporal artery biopsies 129
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 129
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 129
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies 128
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 127
Testo-atlante sulle Uveiti 125
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 125
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 125
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 119
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III 119
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 116
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 116
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 116
Beta-adrenergic antagonists in the treatment of glaucoma 115
Yag laser iridotomy in pigment dispersion syndrome: 10 years later 113
Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon 108
Objective Quantification of Anterior Chamber Inflammation: Measuring Cells and Flare by Anterior Segment Optical Coherence Tomography 108
Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series 108
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 105
Ocular inflammatory events following COVID-19 vaccination: a multinational case series 105
Cogan’s syndrome 104
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 104
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study 104
Unilateral Ocular Pseudopemphigoid in a Patient With Glaucoma 103
Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis 102
Totale 17.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 0 96 86
2021/20221.865 47 92 97 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20255.374 95 46 75 337 1.158 840 495 239 685 294 330 780
2025/20269.385 556 376 1.082 1.538 904 701 1.297 801 937 876 317 0
Totale 24.065